TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $460 | -90.3% | 55 | -71.1% | 0.00% | – |
| Q2 2023 | $4,720 | +66.0% | 190 | +0.5% | 0.00% | – |
| Q1 2023 | $2,843 | -58.9% | 189 | -67.7% | 0.00% | – |
| Q4 2022 | $6,920 | -99.8% | 585 | -99.9% | 0.00% | -100.0% |
| Q3 2022 | $3,449,000 | -63.7% | 582,421 | -73.9% | 0.01% | -61.5% |
| Q2 2022 | $9,499,000 | +27.6% | 2,234,979 | +185.6% | 0.03% | +52.9% |
| Q1 2022 | $7,442,000 | +2218.4% | 782,533 | +12576.7% | 0.02% | +1600.0% |
| Q4 2020 | $321,000 | -71.2% | 6,173 | -85.2% | 0.00% | -66.7% |
| Q3 2020 | $1,115,000 | -85.6% | 41,652 | -89.5% | 0.00% | -84.2% |
| Q2 2020 | $7,753,000 | +746.4% | 398,008 | +327.7% | 0.02% | +533.3% |
| Q1 2020 | $916,000 | +45700.0% | 93,051 | +46425.5% | 0.00% | – |
| Q4 2019 | $2,000 | -99.8% | 200 | -99.7% | 0.00% | -100.0% |
| Q2 2018 | $982,000 | +20.2% | 74,643 | +29.7% | 0.00% | +50.0% |
| Q1 2018 | $817,000 | – | 57,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |